Authors: Apfel, CM Evers, S Hubschwerlen, C Pirson, W Page, MGP Keck, W

Citation: Cm. Apfel et al., Peptide deformylase as an antibacterial drug target: Assays for detection of its inhibition in Escherichia coli cell homogenates and intact cells, ANTIM AG CH, 45(4), 2001, pp. 1053-1057

Authors: Apfel, CM Locher, H Evers, S Takacs, B Hubschwerlen, C Pirson, W Page, MGP Keck, W

Citation: Cm. Apfel et al., Peptide deformylase as an antibacterial drug target: Target validation andresistance development, ANTIM AG CH, 45(4), 2001, pp. 1058-1064

Authors: Apfel, C Banner, DW Bur, D Dietz, M Hubschwerlen, C Locher, H Marlin, F Masciadri, R Pirson, W Stalder, H

Citation: C. Apfel et al., 2-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)- and 2-(2,2-dioxo-1,4-dihydro-2H-2 lambda(6)-benzo[1,2,6]thiadiazin-3-yl)-N-hydroxy-acetamides as potent andselective peptide deformylase inhibitors, J MED CHEM, 44(12), 2001, pp. 1847-1852

Authors: Apfel, C Banner, DW Bur, D Dietz, M Hirata, T Hubschwerlen, C Locher, H Page, MGP Pirson, W Rosse, G Specklin, JL

Citation: C. Apfel et al., Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents, J MED CHEM, 43(12), 2000, pp. 2324-2331